Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Cardinal Health (CAH) ended the recent trading session at $124.71, demonstrating a +0.55% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1 ...

Acting Chief Health Inspector Luke Vonotabua is visiting the Environmental Health team and delivering crucial supplies to aid in the Western Division’s recovery efforts. Vonotabua’s visit includes ...

2024 was packed with health care innovations, from a new blood test detecting Alzheimer’s disease to deep brain stimulation reversing paralysis. Heading into the New Year, medical experts are ...